共 50 条
- [31] Efficacy Evaluation of Tocilizumab with the New ACR/EULAR Remission Criteria and DAS28-ESR. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S498 - S498
- [34] Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis Clinical Rheumatology, 2021, 40 : 2665 - 2672
- [37] Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort BMC MUSCULOSKELETAL DISORDERS, 2017, 18 : 1 - 9
- [38] Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort BMC Musculoskeletal Disorders, 18
- [40] Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis Rheumatology and Therapy, 2021, 8 : 693 - 710